In vivo study for the hemostatic efficacy and foreign body reaction of a new powder-type polysaccharide hemostatic agent.

Published in: Annals of surgical treatment and research (2022)

, and its hemostatic performance was comparable with that of an existing agent, Arista AH. Further clinical studies are required in the future.

Keyphrases